ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

GRCL Gracell Biotechnologies Inc

10.25
0.00 (0.00%)
2024年5月10日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Gracell Biotechnologies Inc GRCL NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.00 0.00% 10.25 09:00:00
始値 安値 高値 終値 前日終値
10.25 10.25
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/0502:22EDGAR2Form 15-12G - Securities registration termination [Section..
2024/2/2814:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/2707:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/2/2707:28EDGAR2Form POS AM - Post-Effective amendments for registration..
2024/2/2707:26EDGAR2Form POS AM - Post-Effective amendments for registration..
2024/2/2707:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/2/2222:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2222:45GLOBEGracell Biotechnologies Acquisition Completed
2024/2/2022:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2021:45GLOBEGracell Biotechnologies Announces Shareholders’ Approval of..
2024/2/1422:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/3020:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2921:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
2024/1/1806:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0906:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0900:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
2023/12/2622:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2620:44DJNGracell ADSs Take Flight Premarket on $1.2 Billion Takeover..
2023/12/2617:05DJNAstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
2023/12/2616:01BWAstraZeneca to acquire Gracell, furthering cell therapy..
2023/12/2616:00GLOBEGracell Biotechnologies to be acquired by AstraZeneca,..
2023/12/2220:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2121:00GLOBEGracell Biotechnologies Announces China NMPA Clearance for..
2023/12/1906:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1209:30GLOBEGracell Biotechnologies Presents Updated Clinical Data from..
2023/11/2920:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
2023/11/2904:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
2023/11/2722:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
2023/11/2120:25EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1622:00GLOBEGracell Biotechnologies to Participate in Inaugural Cell..
2023/11/1420:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/1321:30GLOBEGracell Biotechnologies Reports Third Quarter 2023 Unaudited..
2023/11/0822:30GLOBEGracell Biotechnologies Wins Overall Immunology Solution of..
2023/11/0222:00GLOBEGracell Biotechnologies to Present Updated Results from..
2023/11/0205:00GLOBEGracell Biotechnologies to Participate in Four Upcoming..
2023/10/3122:00GLOBEGracell Biotechnologies to Present Data Highlighting..
2023/10/3021:30GLOBEGracell Biotechnologies to Report Third Quarter 2023..
2023/9/2919:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2721:30GLOBEGracell Biotechnologies Reports Updated Clinical Data for..
2023/9/2719:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2705:00GLOBEGracell Biotechnologies Doses First Patient in Phase 1b/2..
2023/9/1922:21GLOBEGracell Biotechnologies’ CEO Dr. William Cao Named to..
2023/9/1422:15GLOBEGracell Biotechnologies to Participate in Three Upcoming..
2023/9/1305:12EDGAR2Form F-3/A - Registration statement by foreign private..
2023/9/0621:00PRNUSGracell Biotechnologies to Present Updated Clinical Data on..
2023/8/2505:10GLOBEGracell Biotechnologies to Participate in Two Upcoming..
2023/8/2505:03EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/8/2319:47EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1905:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/8/1505:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄